tiprankstipranks
Trending News
More News >
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market

Anthera Pharmaceuticals (ANTH) Income Statement

Compare
236 Followers

Anthera Pharmaceuticals Income Statement

Last quarter (Q1 2018), Anthera Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Anthera Pharmaceuticals's net income was $-4.43M. See Anthera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -281.00K
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 36.53M
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K$ 281.00K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ -26.59M
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -36.43M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 9.56M
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -26.87M
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -16.93M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.65
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.65
Weighted Average Shares Outstanding
22.17M 22.17M 22.17M 22.17M 10.28M
Weighted Average Shares Outstanding (Diluted)
22.17M 22.17M 22.17M 22.17M 10.28M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History